Search: onr:"swepub:oai:DiVA.org:uu-487859" >
Unrelated adult ste...
Unrelated adult stem cell donor medical suitability : recommendations from the World Marrow Donor Association Clinical Working Group Committee.
-
Lown, R N (author)
-
Philippe, J (author)
-
Navarro, W (author)
-
show more...
-
van Walraven, S M (author)
-
Philips-Johnson, L (author)
-
Fechter, M (author)
-
Pawson, R (author)
-
- Bengtsson, M (author)
- Uppsala universitet,Institutionen för immunologi, genetik och patologi
-
Beksac, M (author)
-
Field, S (author)
-
Yang, H (author)
-
Shaw, B E (author)
-
show less...
-
(creator_code:org_t)
- 2014-04-07
- 2014
- English.
-
In: Bone Marrow Transplantation. - : Springer Science and Business Media LLC. - 0268-3369 .- 1476-5365. ; 49:7, s. 880-6
- Related links:
-
https://www.nature.c...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- The World Marrow Donor Association (WMDA) fosters collaboration between international registries to facilitate the exchange of hematopoietic stem cell products for unrelated stem cell donor transplantation. As indications for hematopoietic SCT grow, the movement of products across the world will increase. Although competent authorities may regulate products within their country, there is a need to protect the best interests of donors and recipients by identifying universal donor medical suitability criteria. Within this report the WMDA provides a background to unrelated adult donor and recipient safety, recommends a common framework for assessing the health of unrelated adult donors at each stage of the donation pathway and presents a novel mechanism for sharing international consensus criteria for individual medical and lifestyle conditions. Wherever possible, these criteria are evidence-based. By establishing a donor medical suitability working group, the WMDA has developed a process through which donor centers and registries may request a consensus opinion on conditions not already listed, as well as challenge existing criteria. Guidance from the WMDA is intended to complement, not supersede, guidance from national competent authorities and international regulatory bodies.
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Lown, R N
-
Philippe, J
-
Navarro, W
-
van Walraven, S ...
-
Philips-Johnson, ...
-
Fechter, M
-
show more...
-
Pawson, R
-
Bengtsson, M
-
Beksac, M
-
Field, S
-
Yang, H
-
Shaw, B E
-
show less...
- Articles in the publication
-
Bone Marrow Tran ...
- By the university
-
Uppsala University